Synlett 2010(17): 2621-2624  
DOI: 10.1055/s-0030-1258577
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of 6-(1,2,3-Triazoloalkyl)-α-Pyrones by a Cascade RCM/CM and Click Chemistry Sequence

Fanny Cros, Jérémy Ruiz, Béatrice Pelotier, Olivier Piva*
Université de Lyon, Université Lyon 1, Institut de Chimie et de Biochimie Moléculaire et Supramoléculaire (ICBMS), UMR 5246 CNRS, Bat Raulin, 43 Bd du 11 novembre 1918, 69622 Villeurbanne cedex, France
Fax: +33(472)448136; e-Mail: piva@univ-lyon1.fr;
Further Information

Publication History

Received 19 July 2010
Publication Date:
23 September 2010 (online)

Abstract

A RCM/CM process followed by a further nucleophilic substitution allowed the formation of an azido pyrone which was implicated into a copper-catalyzed [3+2] cycloaddition with various alkynes. Among the different conditions tested, the use of copper(II) salts furnished the expected adducts in a range of 42-99% yield.

    References and Notes

  • 1 de Fatima A. Modolo LV. Conegero LS. Pilli RA. Ferreira CV. Kohn LK. de Carvalho JE. Curr. Med. Chem.  2006,  13:  3371 
  • 2 Meragelman TL. Scuderio DA. Davis RE. Staudt LM. McCloud TG. Cardellina JH. Shoemaker RH. J. Nat. Prod.  2009,  72:  336 
  • 3 Mohapatra DK. Das PP. Reddy DS. Yadav JS. Tetrahedron Lett.  2009,  50:  5941 
  • 4 Reddy DK. Shekhar V. Reddy TS. Reddy SP. Venkateswarlu Y. Tetrahedron: Asymmetry  2009,  20:  2315 
  • 5 Redipalli G. Venkataiah M. Fadnavis NW. Tetrahedron: Asymmetry  2010,  21:  320 
  • 6 Virolleaud MA. Bressy C. Piva O. Tetrahedron Lett.  2003,  44:  8081 
  • 7 Virolleaud MA. Piva O. Synlett  2004,  2087 
  • 8 Cros F. Pelotier B. Piva O. Eur J. Org. Chem.  2010, in press
  • 9a Grubbs RH. Chang S. Tetrahedron  1998,  54:  4413 
  • 9b Fürstner A. Angew. Chem. Int. Ed.  2000,  39:  3012 
  • 9c Schrock RR. Hoveyda AH. Angew. Chem. Int. Ed.  2003,  42:  4592 
  • 9d Boeda FH. Clavier H. Nolan SP. Chem. Commun.  2008,  2726 
  • For other applications of RCM/CM of trienes in synthesis, see:
  • 10a Quinn KJ. Isaacs AK. Arvary RA. Org. Lett.  2004,  6:  4143 
  • 10b Quinn KJ. Isaacs AK. DeChristopher BA. Szklarz SC. Arvary RA. Org. Lett.  2005,  7:  1243 
  • 10c Quinn KJ. Smith AG. Cammarano CM. Tetrahedron  2007,  63:  4881 
  • 10d Riache N. Blond A. Nay B. Tetrahedron  2008,  64:  10853 
  • 10e Enquist JA. Stoltz BM. Nature (London)  2008,  453:  1228 
  • 10f Crimmins MT. Jacobs DL. Org. Lett.  2009,  11:  2695 
  • 10g Quinn KJ. Curto JM. McGrath KP. Biddick NA. Tetrahedron Lett.  2009,  50:  7121 
  • 11a Tomoe CW. Christensen C. Meldal M. J. Org. Chem.  2002,  67:  3057 
  • 11b Rostovtsev VV. Green LG. Fokin VV. Sharpless KB. Angew. Chem. Int. Ed.  2002,  41:  2596 
  • 12 Bock VD. Hiemstra H. van Maarseveen JH. Eur. J. Org. Chem.  2006,  51 
  • 13a Bock VD. Speijer D. Hiemstra H. van Maarseveen JH. Org. Biomol. Chem.  2007,  5:  971 
  • 13b Hartwig S. Hecht S. Macromolecules  2010,  43:  242 
  • 14 Bressy C. Bargiggia F. Guyonnet M. Arseniyadis S. Cossy J. Synlett  2009,  565 
  • 15a Ono K. Nagata T. Nishida A. Synlett  2003,  1207 
  • 15b Young DGJ. Burlison JA. Peters U. J. Org. Chem.  2003,  68:  3494 
  • 15c Rosillo M. Casarrubios L. Dominguez G. Pérez-Castells J. Org. Biomol. Chem.  2003,  1:  1450 
  • 15d Geng X. Danishefsky SJ. Org. Lett.  2004,  6:  413 
  • 15e Yang ZG. Geng X. Solit D. Pratilas CA. Rosen N. Danishesfsky SJ. J. Am. Chem. Soc.  2004,  126:  7881 
  • 15f Ortega N. Martin T. Martin VS. Org. Lett.  2006,  8:  871 
  • 16 Pirrung MC. Biswas G. Ibarra-Rivera TR. Org. Lett.  2010,  12:  2402 
  • 17a Metathesis in Natural Product Synthesis   Cossy J. Arseniyadis S. Meyer C. Wiley-VCH; Weinheim: 2010. 
  • 17b Grubbs RH. Tetrahedron  2004,  60:  7117 
  • 17c Connon SJ. Blechert S. Angew. Chem. Int. Ed.  2003,  42:  1900 
  • 18a Schilling C. Jung N. Bräse S. In Organic Azides, Syntheses and Applications   Bräse S. Banert K. Wiley; Chichester: 2010.  p.269-284  
  • 18b Holub JM. Kirschenbaum K. Chem. Soc. Rev.  2010,  39:  1325 
  • 18c Amblard F. Cho JH. Schinazi RF. Chem. Rev.  2009,  109:  4207 
  • 18d Gil MV. Arévalo MJ. Lopez O. Synthesis  2007,  1589 
  • 19 Davies MB. Polyhedron  1992,  11:  285 
  • 20 Brotherton WS. Michaels HA. Simmons JT. Clark RJ. Dalal NS. Zhu L. Org. Lett.  2009,  11:  4954 
  • 21a Sevin A. Chodkiewicz W. Cadiot P. Tetrahedron Lett.  1965,  1953 
  • 21b Bohlmann F. Schönowsky W. Inhoffen E. Grau G. Chem. Ber.  1964,  97:  794 
  • 22a Tsubuki M. Knai K. Nagase H. Honda T. Tetrahedron  1999,  55:  2493 
  • 22b Binder JT. Kirsch SF. Chem. Commun.  2007,  4164 
  • 22c Menz H. Kirsch SF. Org. Lett.  2009,  11:  5634 
23

Tandem RCM/CM Process: A solution of ester 3 (250 mg, 1.5 mmol) and 4-bromobutene (0.45 mL, 4.3 mmol) in CH2Cl2 (150 mL) was deoxygenated by bubbling argon for 10 min. Grubbs’ II catalyst (2; 32 mg, 0.04 mmol) was added at once and the resulting solution was heated at 40 ˚C until complete disappearance of the starting material (TLC control). The solution was concentrated and purified by flash chromatography on silica leading to 4 as a colorless oil. Compound 4: ¹H NMR (300 MHz, CDCl3): δ = 2.48 (br t, J = 6.0 Hz, 2 H), 2.58 (br q, J = 6.0 Hz, 2 H), 3.03-3.05 (m, 2 H), 3.38 (t, J = 6.9 Hz, 2 H), 5.00-5.03 (m, 1 H), 5.33-5.60 (m, 2 H), 5.86 (br s, 2 H). ¹³C NMR (75 MHz, CDCl3): δ = 29.9, 32.2, 35.8, 38.5, 78.9, 121.8, 125.7, 126.3, 131.7, 168.8. IR: 701, 734, 972, 1073, 1226, 1267, 1380, 1738, 2923, 3034 cm. HRMS: m/z [M] calcd for C10H13O2Br: 245.0177; found: 245.0177. Compound 5: ¹H NMR (300 MHz, CDCl3): δ = 2.29-2.38 (m, 2 H), 2.46-2.50 (m, 2 H), 3.03-3.05 (m, 2 H), 3.29 (t, J = 6.8 Hz, 2 H), 4.98-5.03 (m, 1 H), 5.55-5.60 (m, 2 H), 5.84-5.87 (m, 2 H). ¹³C NMR (75 MHz, CDCl3): δ = 30.0, 32.2, 38.7, 50.8, 79.0, 122.0, 125.8, 126.4, 131.0, 168.8. IR: 701, 734, 972, 1073, 1226, 1267, 1380, 1738, 2923, 3034 cm. HRMS: m/z [M + H+] calcd for C10H14O2N3: 208.1086; found: 208.1085.

24

Compound 7a: ¹H NMR (300 MHz, CDCl3): δ = 2.37-2.63 (m, 2 H), 2.65-2.93 (m, 2 H), 2.93-2.95 (m, 2 H), 4.40-4.46 (m, 2 H), 4.89-4.92 (m, 1 H), 5.41-5.60 (m, 2 H), 5.67-5.79 (m, 2 H), 7.29-7.35 (m, 1 H), 7.39-7.44 (m, 2 H), 7.76 (s, 1 H), 7.79-7.83 (m, 2 H). ¹³C NMR (75 MHz, CDCl3): δ = 29.7, 33.2, 38.3, 49.7, 78.5, 122.0, 121.8, 125.4, 127.1, 127.9, 128.6, 129.5, 130.5, 145.2, 147.2, 168.8. IR: 732, 911, 1049, 1076, 1226, 1382, 1736, 2925, 3136 cm. HRMS:
m/z [M + Na+] calcd for C18H19O2N3: 332.1375; found: 332.1375. Compound 7b: ¹H NMR (300 MHz, CDCl3): δ = 0.91 (t, J = 7.1 Hz, 3 H), 1.36 (sext, J = 7.1 Hz, 2 H), 1.63 (quint, J = 7.1 Hz, 2 H), 2.38-2.43 (m, 2 H), 2.56-2.62 (m, 2 H), 2.69 (t, J = 7.1 Hz, 2 H), 2.99-3.03 (m, 2 H), 4.33 (td, J = 6.8, 2.2 Hz, 2 H), 4.91-4.94 (m, 1 H), 5.40-5.56 (m, 2 H), 5.71-5.89 (m, 2 H), 7.28 (s, 1 H). ¹³C NMR (75 MHz, CDCl3): δ = 13.8, 22.3, 25.3, 29.9, 31.6, 33.5, 38.6, 49.7, 78.8, 120.8, 122.0, 125.7, 127.1, 128.8, 130.0, 168.8. IR: 1049, 1225, 1379, 1735, 2930, 3042 cm. HRMS: m/z [M + H+] calcd for C16H24O2N3: 290.1869; found: 290.1869. Compound 7c: ¹H NMR (300 MHz, CDCl3): δ = 0.57 (td,
J = 7.0, 2.3 Hz, 3 H), 0.95 (br s, 12 H), 1.27 (t, J = 6.9 Hz, 2 H), 2.04-2.17 (m, 2 H), 2.28-2.39 (m, 2 H), 2.70 (d, J = 3.6 Hz, 2 H), 3.20 (t, J = 6.8 Hz, 2 H), 4.05-4.09 (m, 2 H), 4.29 (s, 2 H), 4.62-4.66 (m, 1 H), 5.11-5.28 (m, 2 H), 5.43-5.48 (m, 1 H), 5.52-5.58 (m, 1 H), 7.26 (s, 1 H). ¹³C NMR (75 MHz, CDCl3): δ = 14.0, 22.5, 26.0, 29.1, 29.3, 29.4, 29.5, 29.8, 31.7, 33.3, 38.4, 49.6, 64.1, 70.7, 78.6, 121.9, 122.4, 125.6, 127.2, 129.7, 145.2, 168.7. IR: 703, 816, 973, 1049, 1097, 1223, 1378, 1462, 1739, 2855, 2926 cm. HRMS:
m/z [M + Na+] calcd for C22H35O3N3: 412.2571; found: 412.2564. Compound 7d: ¹H NMR (300 MHz, CDCl3): δ = 2.27-2.47 (m, 2 H), 2.70-2.59 (m, 2 H), 3.00 (m, 2 H), 3.91 (s, 3 H), 4.40-4.46 (m, 2 H), 4.87-4.97 (m, 1 H), 5.37-5.56 (m, 2 H), 5.68-5.73 (m, 1 H), 5.79-5.84 (m, 1 H), 8.08 (s, 1 H). ¹³C NMR (75 MHz, CDCl3): δ = 29.9, 33.2, 38.4, 50.1, 52.1, 78.6, 122.1, 125.6, 127.6, 127.9, 129.1, 139.7, 161.1, 168.8. IR: 2952, 1735, 1543, 1435, 1370, 1228, 1161, 1046, 974, 809, 777, 701 cm. HRMS: m/z [M + Na+] calcd for C14H17O4N3: 314.1111; found: 314.1103. Compound 7e: ¹H NMR (300 MHz, CDCl3): δ = 0.29 (s, 9 H), 2.37-2.42 (m, 2 H), 2.57-2.70 (m, 2 H), 2.98-3.01 (m, 2 H), 4.36-4.44 (m, 2 H), 4.88-4.93 (m, 1 H), 5.46-5.56 (m, 2 H), 5.69-5.75 (m, 1 H), 5.79-5.86 (m, 1 H), 7.51 (s, 1 H). ¹³C NMR (75 MHz, CDCl3): δ = -1.0, 29.9, 33.6, 38.6, 49.3, 78.8, 121.9, 125.7, 127.1, 129.1, 129.9, 146.4, 168.8. IR: 701, 760, 843, 973, 1050, 1194, 1249, 1379, 1739, 2956 cm. HRMS: m/z [M + Na+] calcd for C15H23O2N3Si: 328.1452; found: 328.1442.

25

Compound 8a: ¹H NMR (300 MHz, CDCl3): δ = 2.12-2.18 (m, 2 H), 2.31-2.46 (m, 2 H), 2.65-2.71 (m, 2 H), 4.27-4.36 (m, 1 H), 4.46 (t, J = 6.7 Hz, 2 H), 5.43-5.62 (m, 2 H), 5.90 (dt, J = 9.7, 1.8 Hz, 1 H), 6.68 (dt, J = 9.7, 4.3 Hz, 1 H),7.30-7.35 (m, 1 H), 7.39-7.44 (m, 2 H), 7.77 (s, 1 H), 7.81-7.85 (m, 2 H). ¹³C NMR (75 MHz, CDCl3): δ = 28.6, 33.5, 37.7, 50.0, 77.1, 121.2, 125.7, 128.2, 128.3, 128.9, 129.1, 129.2, 130.6, 145.1, 147.1, 164.3. IR: 731, 909, 1047, 1227, 1386, 1731, 2924, 3031 cm. HRMS: m/z [M + H+] calcd for C18H20O2N3: 310.1555; found: 310.1555. Compound 8b: ¹H NMR (300 MHz, CDCl3): δ = 0.92 (t, J = 7.0 Hz, 3 H), 1.37 (sext., J = 7.8 Hz, 2 H), 1.63 (quint, J = 7.8 Hz, 2 H), 2.19-2.23 (m, 2 H), 2.32-2.47 (m, 2 H), 2.57-2.63 (m, 2 H), 2.68 (t, J = 7.8 Hz, 2 H), 4.36 (t, J = 6.8 Hz, 2 H), 4.28-4.41 (m, 1 H), 5.46-5.50 (m, 2 H), 6.00 (dt, J = 9.8 Hz, 1.9 Hz, 1 H), 6.86 (dt, J = 9.8, 4.5 Hz, 1 H), 7.27 (s, 1 H). ¹³C NMR (75 MHz, CDCl3): δ = 13.8, 22.2, 25.3, 28.5, 31.6, 33.4, 37.6, 49.6, 77.1, 120.6, 121.1, 127.7, 129.3, 145.2, 148.3, 164.2. IR: 2955, 2929, 2858, 1719, 1550, 1459, 1433, 1387, 1249, 1148, 1133, 1043, 972, 816, 666 cm. HRMS: m/z [M + H+] calcd for C16H24O2N3: 290.1863; found: 290.1862. Compound 8c: ¹H NMR (300 MHz, CDCl3): δ = 0.83 (t, J = 7.0 Hz, 3 H), 1.22 (br s, 12 H), 1.50-1.57 (m, 2 H), 2.13-2.29 (m, 2 H), 2.31-2.45 (m, 2 H), 2.56-2.67 (m, 2 H), 3.46 (t, J = 6.8 Hz, 2 H), 4.30-4.41 (m, 1 H), 4.36 (t, J = 6.9 Hz, 2 H), 4.55 (s, 2 H), 5.39-5.56 (m, 2 H), 5.96 (d, J = 9.6 Hz, 1 H), 6.81-6.87 (m, 1 H), 7.52 (s, 1 H). ¹³C NMR (75 MHz, CDCl3): δ = 14.1, 22.7, 26.1, 28.6, 29.3, 29.5, 29.6, 29.7, 31.9, 33.4, 37.7, 49.9, 64.3, 71.0, 77.1, 121.2, 122.5, 128.0, 129.1, 145.2, 145.5, 164.3. IR: 666, 814, 971, 1044, 1097, 1245, 1382, 1429, 1459, 1720, 2851, 2926 cm. HRMS:
m/z [M + Na+] calcd for C22H35O3N3: 412.2571; found: 412.2566. Compound 8d: ¹H NMR (300 MHz, CDCl3): δ = 2.18-2.27 (m, 2 H), 2.29-2.46 (m, 2 H), 2.61-2.75 (m, 2 H), 3.92 (s, 3 H), 4.35 (q, J = 6.2 Hz, 1 H), 4.46 (t, J = 7.0 Hz, 2 H), 5.40-5.64 (m, 2 H), 5.99 (d, J = 9.9 Hz, 1 H), 6.81-6.87 (m, 1 H), 8.08 (s, 1 H). ¹³C NMR (75 MHz, CDCl3): δ = 28.6, 33.3, 37.6, 50.2, 52.2, 77.0, 121.2, 127.6, 127.7, 128.6, 128.6, 145.2, 161.1, 164. 2. IR: 778, 815, 1044, 1207, 1231, 1248, 1366, 1387, 1435, 1543, 1720, 2917, 2950 cm. HRMS: m/z [M + Na+] calcd for C14H17O4N3: 314.1111; found: 314.1106. Compound 8e: ¹H NMR (300 MHz, CDCl3): δ = 0.28 (s, 9 H), 2.17-2.22 (m, 2 H), 2.25-2.47 (m, 2 H), 2.57-2.69 (m, 2 H), 4.30-4.43 (m, 1 H), 4.40 (t, J = 6.9 Hz, 2 H), 5.45-5.50 (m, 2 H), 5.97 (dt, J = 9.6, 1.7 Hz, 1 H), 6.81-6.87 (m, 1 H), 7.50 (s, 1 H). ¹³C NMR (75 MHz, CDCl3): δ = -1.0, 28.7, 33.6, 37.8, 49.3, 77.2, 121.3, 127.8, 127.9, 129.0, 129.3, 145.2, 146.6, 164.3. IR: 655, 759, 816, 843, 972, 1043, 1116, 1146, 1194, 1249, 1387, 1424, 1490, 1719, 2851, 2917, 2955 cm. HRMS: m/z [M + Na+] calcd for C15H23O2N3Si: 328.1452; found: 328.1440.